Release Date: 2024-06-19
Current Management of Metastatic Prostate Cancer
Asif Yildirim (Editor), Ozgur Kazan (Editor), Ahmet Keles (Editor), Mehmet Caglar Cakici (Editor)
Release Date: 2024-06-19
Alcohol is a general term used to refer to chemical structures containing the hydroxyl (-OH) radical group. In daily life, it refers to a type of alcohol, usually called ethanol. When alcohol is ingested into the body, a series of chemical effects occur, especially in the liver. The elimination process that begins when alcohol is [...]
| Work Type | Edited Book |
|---|---|
| Internal Reference | NBL70 |
| Edition | 1 |
| DOI | https://doi.org/10.69860/nobel.9786053359142 |
| ISBN | 978-605-335-914-2 (PAPERBACK) |
| Page Count | 210 |
| Print Lenght | x+199 |
| Place | Istanbul |
| Copyright Holder | Nobel Tıp Kitabevleri |
| License | https://nobelpub.com/publish-with-us/copyright-and-licensing |
| BIC | MJCL |
|---|---|
| BISAC | MED062000 |
| THEMA | MJCL |
- Histopathological and Molecular Markers of Metastatic Prostate Cancer (pp. 1-21)
Nagehan Ersoy Tunali, Ceyda Nur Zaim - Lhrh Agonist and Antagonist for Metastatic Prostate Cancer (pp. 23-34)
Bekir Demirtas, Ozgur Kazan - Radical Prostatectomy As a Local Therapy in the Management of Patients with Oligometastatic Prostate Cancer (pp. 35-43)
Ferhat Keser, Mehmet Caglar Cakici - Role of Metastasectomy in Prostate Cancer Patients Following Curative Treatment (pp. 45-54)
Ahmet Keles, Burak Tufekci - Radiotherapy As a Local Therapy in the Management of Patient with Oligometastatic Prostate Cancer (pp. 55-67)
Ayberk Iplikci, Ozgur Efiloglu - Systemic Chemotherapy for Metastatic Prostate Cancer (pp. 69-77)
Selamettin Demir, Muhammet Cicek - Enzalutamide Therapy for Metastatic Prostate Cancer (pp. 79-88)
Turgay Turan, Yunus Erol Bozkurt - Abiraterone Acetate Treatment in Metastatic Prostate Cancer (pp. 89-96)
Hakan Polat, Yavuz Onur Danacioglu - Apalutamide Therapy for Metastatic Prostate Cancer (pp. 97-104)
Eyyup Sabri Pelit, Mustafa Kaan Akalin - Darolutamide Therapy for Metastatic Prostate Cancer (pp. 105-109)
Kenan Toprak, Meftun Culpan - Parp Inhibitors Therapy for Metastatic Prostate Cancer (pp. 111-120)
Erdinc Dincer, Cengiz Canakci - Combined Treatments for Metastatic Prostate Cancer (pp. 121-129)
Onur Alkan, Sinan Koca - Immunotherapy for Prostate Cancer (pp. 131-139)
Ilkin Hamid-Zada, Ozgur Arikan - Rational Sequential Treatment Options for Metastatic Prostate Cancer (pp. 141-150)
Aydin Acarbey, Mahmut Gumus - Bone Health and Bone Targeted Therapies for Metastatic Prostate Cancer (pp. 151-160)
Halil Lutfi Canat, Adem Alcin - Quality of Life Outcomes After the Management of Metastatic Prostate Cancer (pp. 161-166)
Alpaslan Yuksel, Elbrus Fehruzlu - Management of Brain Metastasis in Patients with Metastatic Prostate Cancer (pp. 185-194)
Berin Gulatar Turkoglu, Kadriye Agan Yildirim - Palliative Care for Metastatic Prostate Cancer (pp. 167-184)
Ferhat Yakup Suceken, Ahmet Tahra
Asif Yildirim (Editor)
Professor, Istanbul Medeniyet University
https://orcid.org/0000-0002-3386-971X
3Dr. Yildirim received his Doctor of Medicine from the Marmara University School of Medicine and started the residency training in the Department of Urology at the Marmara University School of Medicine in 1995. He completed his urological residency in 2000. He earned the degrees of Associate Professor in 2010, and Professor of Urology in 2016, and by February 2016 he joined the Department of Urology at Medical School of Medeniyet University. Dr. Yildirim specialized in the treatment of genitourinary cancers, including prostate cancer, bladder cancer, renal cancer and testicular cancer. His research interests include imaging, pathology and genetics of prostate cancer, bladder cancer and renal cancer.
Ozgur Kazan (Editor)
Istanbul Medeniyet University
https://orcid.org/0000-0003-0202-0454
3Huseyin Ozgur Kazan, M.D., FEBU, is a dedicated urologist specializing in urooncology, proficient in diverse surgical techniques including laparoscopic and endoscopic procedures. With a commitment to patient-centered care, he continuously enhances his expertise through ongoing professional development and clinical research. Fluent in English and German, he graduated from Ege University Faculty of Medicine and completed his residency at Istanbul Medeniyet University Faculty of Medicine Prof. Dr. Süleyman Yalçın City Hospital. His professional journey includes roles at various hospitals, including Kocaeli State Hospital and Kütahya Health Sciences University Evliya Çelebi Training and Research Hospital. Currently, he serves as a Urology Specialist at Istanbul Medeniyet University Faculty of Medicine Prof. Dr. Süleyman Yalçın City Hospital. Notably, his research, supported by TÜBİTAK, focused on the prognostic role of PI3K and JAK/STAT pathways in regulating PDL-1 expression in prostate cancer.
Ahmet Keles (Editor)
Istanbul Medeniyet University
https://orcid.org/0000-0001-5436-1803
3Dr. Ahmet Keles earned his Doctor of Medicine (MD) degree from Akdeniz University School of Medicine and completed his residency in residency in the Department of Urology at Marmara University Faculty of Medicine. During his residency, he achieved certification in European Basic Laparoscopic Urological Skills (E-BLUS) and became a Fellow of the European Board of Urology (FEBU). To further specialize, Dr. Keles underwent rigorous endourology training under Prof. Dr. Jean de la Rosette at Amsterdam Academic Medical Center (AMC) through the prestigious European Urological Scholarship Programme (EUSP). Currently, he is expanding his expertise as a Urologist at Istanbul Medeniyet University Faculty of Medicine. Dr. Keles’s research has resulted in nearly 30 scientific publications in peer-reviewed journals and numerous presentations at national and international conferences. Additionally, he has contributed to the field by authoring six book chapters in urology and oncology. He is also a member of the European Association of Urology (EAU) and the American Urological Association (AUA).
Mehmet Caglar Cakici (Editor)
Associate Professor, Istanbul Medeniyet University
https://orcid.org/0000-0002-0176-5887
3Mehmet Çağlar Çakıcı completed his undergraduate education at Gazi University Faculty of Medicine in 2012. He finished his urology specialization training in 2018 at Ankara Diskapi Yildirim Beyazit Training and Research Hospital. In the same year, he started working as a urology specialist at Istanbul Medeniyet University Goztepe Training and Research Hospital, and he currently continues his work at the same hospital as an associate professor. He has authored over seventy articles and participated as an investigator in ten clinical studies.
| onix_3.0::thoth | Thoth ONIX 3.0 |
|---|---|
| onix_3.0::project_muse | Project MUSE ONIX 3.0 |
| onix_3.0::oapen | OAPEN ONIX 3.0 |
| onix_3.0::jstor | JSTOR ONIX 3.0 |
| onix_3.0::google_books | Google Books ONIX 3.0 |
| onix_3.0::overdrive | OverDrive ONIX 3.0 |
| onix_2.1::ebsco_host | EBSCO Host ONIX 2.1 |
| csv::thoth | Thoth CSV |
| json::thoth | Thoth JSON |
| kbart::oclc | OCLC KBART |
| bibtex::thoth | Thoth BibTeX |
| doideposit::crossref | CrossRef DOI deposit |
| onix_2.1::proquest_ebrary | ProQuest Ebrary ONIX 2.1 |
| marc21record::thoth | Thoth MARC 21 Record |
| marc21markup::thoth | Thoth MARC 21 Markup |
| marc21xml::thoth | Thoth MARC 21 XML |
Bria Rosario –
It constitutes an excellent source of information on the subject of prostate cancer.